THE Therapeutic Goods Administration is conducting further investigation into high-risk schedule 4 drugs such as pregabalin, which has been associated with 88 deaths in NSW.
CLICK HERE to access the NHMRC sponsored paper in Addiction.
The above article was sent to subscribers in Pharmacy Daily's issue from 30 Aug 18
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 30 Aug 18